Perioperative DCF chemotherapy protocol for patients with gastroesophageal adenocarcinoma: correlation between response to treatment and outcome

To determine whether metabolic or pathological response to preoperative chemotherapy can predict the relapse-free survival of gastroesophageal adenocarcinoma patients treated on a perioperative chemotherapy protocol. The prospectively collected data of a recently reported phase II trial of periopera...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Medical oncology (Northwood, London, England) London, England), 2013-03, Vol.30 (1), p.377, Article 377
Hauptverfasser:	Alcindor, T., Ferri, L. E., Marcus, V., Andalib, A., Hickeson, M., Artho, G., Chasen, M., Thirlwell, M. P., Ades, S.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenocarcinoma - drug therapy Adenocarcinoma - mortality Adenocarcinoma - surgery Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Chemotherapy, Adjuvant Cisplatin - administration & dosage Cisplatin - adverse effects Disease-Free Survival Esophageal Neoplasms - drug therapy Esophageal Neoplasms - mortality Esophageal Neoplasms - surgery Female Fluorouracil - administration & dosage Fluorouracil - adverse effects Hematology Humans Internal Medicine Male Medicine Medicine & Public Health Middle Aged Oncology Original Paper Pathology Stomach Neoplasms - drug therapy Stomach Neoplasms - mortality Stomach Neoplasms - surgery Taxoids - administration & dosage Taxoids - adverse effects Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!